The New York State Podiatry Political Action Committee (NYPPAC) is a nonprofit, bipartisan fundraising committee through which podiatrists support state candidates who champion podiatric medicine's issues In New York.
Dear Colleagues: Last Friday, President Trump promised to “derail the gravy train” in the health-care system in a speech in which he unveiled his much-anticipated strategy to lower drug prices.
When prescription-drug benefits were added to Medicare under a 2003 law, the pharmaceutical industry successfully lobbied to prohibit the federal government from using its huge purchasing power to negotiate drug prices.
We are also the largest statewide component of the American Podiatric Medical Association.
NYSPMA members adhere to a code of strict ethical standards and participate in numerous programs to benefit patients, the podiatric profession and the general public.
10094 – Carroll) from the Transportation committee to the Senate floor that would require a licensed physician, physician assistant or nurse practitioner to report patients that have a chronic condition which cause or may cause unconsciousness or unawareness to the Department of Motor Vehicles.
The conditions include a convulsive disorder, epilepsy, fainting, dizzy spells, coronary ailments or other health conditions that may impair the ability to operate a motor vehicle.
Drugs for common ailments like diabetes and asthma routinely see price hikes around 10 percent annually.
Meanwhile, some companies have been buying up once-cheap older drugs and raising prices by 1,000 percent or more.
Our Council has taken a deep dive into the escalating cost of insulin at the request of our AMA members.
We have come up with some specific strategies that the practicing physician can use to help their patients now, and some suggestions to improve general affordability moving forward.
Slightly more than half responded that enacting policies to lower them should be our government’s top policy priority.
One of the other hats that I wear, and welcomed in anticipation of becoming your President, is as a member of the AMA Council on Medical Service.
I have remarked to my fellow Council members that looking at drug prices is like peeling an onion. We need political leaders that are willing to stand up to the power of the pharmaceutical industry.